| Model Number |
7300TFX |
| Medical Device Problem Code |
Device Stenosis (4066)
|
| Health Effect - Clinical Code |
Insufficient Information (4580)
|
| Date of Event |
07/10/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
H10: additional manufacturer narrative:the investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
| |
|
Event or Problem Description
|
|
It was reported that a patient with a 33mm 7300tfx mitral valve, implanted for 9 years and 1 month underwent attempted valve-in-valve procedure due to stenosis.Tee showed a large clot in the left atrium and procedure was cancelled.Plan is for repeat tee on (b)(6) 2025 and if clot has resolved patient will be scheduled for tmvr on (b)(6) 2025.
|
| |
|
Additional Manufacturer Narrative
|
|
H10: additional manufacturer narrative: updated sections b5, b7, h6 (device code and impact code).Stenosis is a common manifestation of bioprosthetic valve and valved conduit dysfunction and has many potential root causes, including structural valve deterioration (svd), non-structural valve dysfunction (nsvd), endocarditis and/or thrombosis.Bioprosthetic device stenosis is typically related to patient and/or procedural factors and is not typically an indication of a device malfunction related to a manufacturing deficiency.There is no evidence to suggest a manufacturing defect caused or contributed to the reported event.The root cause of this event cannot be conclusively determined with the available information.However, the stenosis in this case was most likely impacted by the progression of the patients underlying valvular disease pathology with or without structural valve deterioration and/or nonstructural dysfunction.The subject device is not available for evaluation, as it remains implanted in the patient.The device history record (dhr) review was completed and this device passed all manufacturing and sterilization inspections prior to release for distribution.There were no issues identified that would have impacted this event.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
| |
|
Event or Problem Description
|
|
It was reported that a patient with a 33mm 7300tfx mitral valve, implanted for 9 years and 1 month is under consideration for valve-in-valve procedure due to stenosis.Tee showed a large clot in the left atrium and procedure was cancelled.
|
| |
|
Search Alerts/Recalls
|